Pharmaceutical industry

Female scientists working in a lab
#ABPI #Biopharmaceuticals #Collaboration #Pharmaceutical industry

Industry-academic collaborations vital for UK pharma workforce

A surge in apprenticeships, placements, and global research collaborations is strengthening the UK’s pharmaceutical workforce.  This is a summary of the key findings from the latest Industry and Academic Links Survey from the Association of the British Pharmaceutical Industry (ABPI).  As National Apprenticeship Week (10-14 February) begins, new figures highlight… Read More

#Business & Investment #News

Vaccine research
#Career #Pharmaceutical industry #Survey

40% of pharma workers see workplace bullying, study reveals

New research has revealed that 40% of workers in the pharmaceutical and life sciences sector have experienced workplace bullying, 9% above the overall average.  The Resilience nation report, commissioned by regulatory and compliance software company Ideagen, gathered insights from over 4,000 individuals in… Read More

#News

#Big pharma #Funding #Patient groups #Pharmaceutical industry #University of Bath

Patient groups influenced by drug company funding, study finds

Action is needed to safeguard the independence of patient organisations and charities, according to the findings of a new study.  The study by the University of Bath, UK, Lund University, Sweden and Kozminski University, Poland, concludes that patient organisations and charities across Europe are at risk of aligning their interests… Read More

#Business & Investment #News

Medical researchers
#Association of the British Pharmaceutical Industry #Biopharma #Career #Pharmaceutical industry

Why is Gen-Z choosing to work in pharma?

Younger workers in the UK are increasingly choosing careers in pharmaceuticals over other industries like technology or finance due to perceptions of better work life balance and social purpose in the sector. This is according to a new report ‘Young people’s perceptions of careers in the… Read More

#News

Judge's gavel
#Association of the British Pharmaceutical Industry #Big pharma #Pharmaceutical industry

Novartis, Pfizer, Otsuka and Novo breach the ABPI Code

The Prescription Medicines Code of Practice Authority (PMCPA) has ruled that Novartis, Pfizer, Otsuka and Novo Nordisk have breached the Association of the British Pharmaceutical Industry (ABPI) Code of Practice. The companies were judged to have “brought discredit upon”, and “reduced confidence in”, the pharmaceutical industry. Read More

#News

Downing Street, London, UK
#Association of the British Pharmaceutical Industry #Pharmaceutical industry #UK #UK government

Changes to UK Statutory Scheme go ahead despite pharma criticism

The UK government has published new terms for the Statutory Scheme for branded medicines, which controls the prices of medicines paid by the NHS. The announcement follows the agreement in mid-November of a new Voluntary Scheme for Pricing, Access and Growth (VPAG), a negotiated alternative scheme which companies can opt… Read More

#Business & Investment #News #Trending News

#Drug delivery #Drug development #Drug discovery #Drug repurposing #Microbiome #Mucoadhesive drug delivery #Pharmaceutical industry #Synthetic biology

New podcast: Outside the box thinking for drug discovery success

This is the latest episode of the free DDW narrated podcast, “Outside the box thinking for drug discovery success”, which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: Stanford researchers construct the most complete synthetic microbiome, … Read More

#News

#ABPI #Association of the British Pharmaceutical Industry #Pharmaceutical industry #UK #UK government

Industry rejects ‘damaging’ changes to UK medicines scheme

Over twenty pharma companies have rejected the UK government’s proposed changes to the statutory scheme for branded medicines, the latest move in an ongoing disagreement between the government and industry. According to the Association of the British Pharmaceutical industry (ABPI), the “radical plans” are “unworkable”. And… Read More

#News

AI brain
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug discovery #Pharmaceutical industry

Pharma must embrace an AI future says new report

Artificial intelligence (AI) technology has the potential to revolutionise drug discovery and pharma companies need to make plans for a future in which AI is frequently utilised in research, says ResearchAndMarkets.com. However, the change AI will bring about in drug discovery will take some time, according to the ‘Global Markets… Read More

#News #Trends & Analysis

UK
#Covid-19 #Global data #Life sciences #Pharmaceutical industry #World

More trust for pharma in the UK than the US

Six out of 10 people in the UK trust pharma businesses to do what is right: up 1% on last year. The UK places more trust in pharma than European neighbours France (52%), Germany (55%), or the industry’s largest global market, the US (54%). Read More

#News

New appointments
#Appointment #Drug discovery #Life sciences #New appointment #Pharmaceutical industry

March’s key industry appointments

A round-up of the latest senior appointments in the drug discovery sector over the last month. Julian Collins, Jana Windt and Michiel Stork, ProBioGen Julian Collins has been appointed as Senior Vice President, Head of People & Organizational Development (P&OD) and a member of the Executive Team. Michiel Stork has taken… Read More

#Business & Investment #News

Novo Nordisk head office
#ABPI #Association of the British Pharmaceutical Industry #Novo Nordisk #Pharmaceutical industry #UK

Novo Nordisk suspended from UK’s ABPI membership

Novo Nordisk has been suspended as a member of the Association of the British Pharmaceutical Industry (ABPI) for two years due to serious breaches of the ABPI Code of Practice. This is the eighth occasion in the past 40 years the ABPI Board has issued such… Read More

#News

Pharmaceuticals manufacturing
#ABPI #Appointment #Association of the British Pharmaceutical Industry #New appointment #Pharmaceutical industry #UK

Susan Rienow confirmed as next President of the ABPI 

The ABPI Board has confirmed that Susan Rienow, UK Country President of Pfizer, will be the next President of the Association of the British Pharmaceutical Industry (ABPI).   Rienow was appointed as ABPI Vice-President in September 2022 and will formally take up her role as President in May… Read More

#News

#Collaboration #Pharma Innovation Council #Pharmaceutical industry #Pistoia Alliance

Pharma Innovation Council will tackle industry barriers

The Pistoia Alliance Pharma Innovation Council has been launched, bringing together 13 leaders from large global pharmaceutical companies.   The Council will explore common challenges at a grassroots level and seed ideas for new pre-competitive projects aligned with the Alliance’s strategic themes: Emerging Sciences and Technology, Improving the… Read More

#News

#Diversity #Gender equality #International Women's Day #Life sciences #Pharmaceutical industry

Balancing the lack of gender equality at top leadership level 

Women in Life Science Denmark (WiLD), an inspiring and science-centric not-for-profit network for women in senior positions across industry and academia, launched in January 2023 to strengthen value creation in the Danish Life Sciences industry, while promoting talent, diversity and inclusiveness. DDW’s Megan Thomas caught up with WiLD to learn… Read More

#Business & Investment #Exclusive Content

International Women's Day
#Diversity #Gender equality #International Women's Day #Life sciences #Pharmaceutical industry

International Women’s Day: Female life science leaders

For International Women’s Day, DDW’s Diana Spencer celebrates some of the women in leadership making an impact on the drug discovery and life sciences sector. The life sciences sector has traditionally outperformed others when it comes to attracting women to its workforce. In its ‘Women in Business 2022’ report, Grant Thornton… Read More

#Exclusive Content